PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Re-evaluating the time of your life

Tel Aviv University researcher investigates the 'subjective time trajectory' in psychological health

2010-10-13
(Press-News.org) In life, we're told, we must take the good with the bad, and how we view these life events determines our well-being and ability to adjust. But according to Prof. Dov Shmotkin of Tel Aviv University's Department of Psychology, you need more than the right attitude to successfully negotiate the vicissitudes of life.

As recently reported in Aging and Mental Health, Prof. Shmotkin's research reveals that people's well-being and their adaptation can be ascertained by their "time trajectory" ― their concept of how they have evolved through their remembered past, currently perceived present, and anticipated future. A close study of how patients compartmentalize their life into these periods can help clinical psychologists treat them more effectively, he says.

From trauma to everyday life

Prof. Shmotkin says that the theory emerged from the study of patients who had experienced traumatic events. "We discovered that overcoming trauma was related to how people organized the memory of their trauma on the larger time continuum of their life course," he explains.

In a study of Holocaust survivors, Prof. Shmotkin separated these survivors into those who considered the "Holocaust as past" and those who conceived of the "Holocaust as present." Those in the "Holocaust as past" category were able to draw an effective line between the present day and the past trauma, thus allowing themselves to move forward. Those in the "Holocaust as present" category considered their traumatic experience as still existing, which indicated a difficulty in containing the trauma within a specific time limit.

But Prof. Shmotkin quickly saw that these coping mechanisms were not exclusive to those who had experienced trauma. Instead, he theorized, these mechanisms are a part of the normal aging process. When young, he explains, our wishes for self improvement and growth lie in an anticipated future. But as we get older, our longer perspective can help or hinder in confronting the present challenges of aging.

A time line to improve patient care

Prof. Shmotkin tested his thesis in collaboration with his former PhD students, Drs. Yuval Palgi and Amit Shrira. They studied participants with an average age of 92 who described their personal time trajectories in terms of their satisfaction with the recent past, the present, and near future.

The best-functioning participants were those whose time trajectory appeared stable rather than "descending," as was expected to occur is very old age, or "ascending," as is normal for youth and adults. Participants at this advanced age also revealed higher well-being when they managed to contrast their present with the suffering they endured in miserable periods of their life. Notably, Holocaust survivors were less able to make this break between the present and the trauma of their past.

This information, says Prof. Shmotkin, is crucial for improving therapeutic care, although it is often overlooked by clinical psychologists. "A person's subjective time frame is key to the formulation of that person's life story and well-being," he explains. Prof. Shmotkin urges psychologists to try to better understand their patients' personal time trajectories, using these as a tool to help patients reconcile their traumatic pasts and the present challenges of aging.

### American Friends of Tel Aviv University (www.aftau.org) supports Israel's leading, most comprehensive and most sought-after center of higher learning. Independently ranked 94th among the world's top universities for the impact of its research, TAU's innovations and discoveries are cited more often by the global scientific community than all but 10 other universities.

Internationally recognized for the scope and groundbreaking nature of its research and scholarship, Tel Aviv University consistently produces work with profound implications for the future.


ELSE PRESS RELEASES FROM THIS DATE:

Sexual issues a major concern for cancer patients taking new targeted drugs

2010-10-13
New drugs that target specific molecular mechanisms of cancer have improved the treatment of cancer patients in recent years, but those benefits may come with a cost to the patient's sex life, researchers have found. At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, French researchers reported on one of the few studies to investigate the impact of cancer therapy on the sexual functioning of patients. Dr Yohann Loriot and Dr Thomas Bessede from Institut Gustave Roussy in Villejuif, France and colleagues found that patients taking ...

Afatinib benefits lung cancer patients whose cancer progressed after treatment with EGFR inhibitors

2010-10-13
Lung cancer patients who have already been treated with the EGFR inhibitors erlotinib or gefitinib seem to gain further benefits in terms of progression-free survival and tumor shrinkage when treated with the new drug afatinib, the results of a Phase IIb/III trial show. At the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy, Dr Vincent Miller from Memorial Sloan-Kettering Cancer Center in New York, USA, reported findings from the LUX-Lung 1 trial of afatinib in 585 patients with lung adenocarcinoma whose cancer had progressed after chemotherapy ...

New Phase II study shows first-line promise of lung cancer drug PF-299

2010-10-13
A new-generation lung cancer drug has shown an impressive ability to prevent disease progression when administered as a first-line treatment in patients with advanced disease, investigators reported at the 35th Congress of the European Society for Medical Oncology (ESMO). Preliminary results from an ongoing Phase-II trial of the drug PF299804 (PF-299) showed that close to 85% of patients whose cancers harbor mutated forms of the EGFR gene have remained progression-free for at least nine months, reported Dr Tony Mok from the Chinese University of Hong Kong. While some ...

Pazopanib shows promise in Phase II trial for relapsed/refractory urothelial cancer

2010-10-13
An ongoing Phase-II trial investigating a new, targeted therapy for metastatic urothelial cancer has generated promising early results, Italian researchers reported at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy. Urothelial cancers affect the tissue lining the inner surfaces of the bladder and other parts of the urinary system. In cases of metastatic disease, median survival is approximately 12-15 months and there is a 10-15% chance of prolonging it by the use of standard chemotherapy regimens, particularly in otherwise healthy ...

Phase III study shows everolimus delays tumor progression in hard-to-treat neuroendocrine tumors

2010-10-13
The results of a large Phase-III clinical trial have shown that the drug everolimus delays tumor progression in patients with a hard-to-treat group of rare cancers that affect particular hormone-producing cells. At the 35th Congress of the European Society for Medical Oncology (ESMO), Dr Marianne Pavel from Charité University in Berlin, Germany reported that everolimus improved progression-free survival by 5.1 months in patients with advanced neuroendocrine tumors. Neuroendocrine tumors are slow-growing malignancies that originate from cells of the body's neuroendocrine ...

Selective strategy could lead to new approaches against schizophrenia

2010-10-13
A new class of compounds identified by researchers at Emory University School of Medicine could be developed into drugs for the treatment of schizophrenia. The compounds enhance signaling by molecules in the brain called NMDA receptors, which scientists believe are functioning at low levels in people with schizophrenia. Led by Stephen Traynelis, PhD, professor of pharmacology, a team of Emory researchers sifted through thousands of chemicals and found one, called CIQ, which could selectively enhance the function of certain NMDA receptors without affecting others. The ...

A picture worth a thousand words: New research links visual cues to male sexual memory

2010-10-13
Iowa City, IA—October 11, 2010— A new study published in Applied Cognitive Psychology finds that college-aged men are very likely to remember a woman's initial sexual interest (attraction or rejection), especially when the woman in question is thought to be attractive, is dressed more provocatively, and expresses positive sexual interest. In the study the men were shown full-body photographs of college-aged women who expressed cues of sexual interest or rejection. The participating males represented mixed sexual histories, and a capacity for varying degrees of sexually ...

University of Florida research provides new understanding of bizarre extinct mammal

University of Florida research provides new understanding of bizarre extinct mammal
2010-10-13
GAINESVILLE, Fla. --- University of Florida researchers presenting new fossil evidence of an exceptionally well-preserved 55-million-year-old North American mammal have found it shares a common ancestor with rodents and primates, including humans.The study published today in the online edition of the Zoological Journal of the Linnean Society, describes the cranial anatomy of the extinct mammal, Labidolemur kayi. High resolution CT scans of the specimens allowed researchers to study minute details in the skull, including bone structures smaller than one-tenth of a millimeter. ...

On the trail of the epigenetic code

On the trail of the epigenetic code
2010-10-13
The genetic inherited material DNA was long viewed as the sole bearer of hereditary information. The function of its packaging proteins, the histones, was believed to be exclusively structural. Additional genetic information can be stored, however, and passed on to subsequent generations through chemical changes in the DNA or histones. Scientists from the Max Planck Institute for Biophysical Chemistry in Göttingen have succeeded in creating an experimental system for testing the function of such chemical histone modifications and their influence on the organism. Chemical ...

Smaller and cheaper but 300 times more intense

2010-10-13
More brilliant X-rays, more cost-effective methods for developing new energy sources and advanced manufacturing processes are just some of the benefits which may come from a novel technology, proven at the theoretical level by a consortium of British and European laser scientists. The research, led by scientists at the Science and Technology Facilities Council's Central Laser Facility is published in this week's edition of Nature Physics (October 10 2010). A team of scientists from the Instituto Superior Tecnico in Lisbon, Imperial College London, and the Universities ...

LAST 30 PRESS RELEASES:

The role of artificial intelligence in advancing intratumoral immunotherapy

Political ideology is associated with differences in brain structure, but less than previously thought

Genetic tracing at the Huanan Seafood market further supports COVID animal origins

Breastfeeding is crucial to shaping infant’s microbes and promoting lung health

Scientists at the CNIC discover an unexpected involvement of sodium transport in mitochondrial energy generation

Origami paper sensors could help early detection of infectious diseases in new simple, low-cost test

Safety of the seasonal influenza vaccine in 2 successive pregnancies

Preconception and early-pregnancy BMI in women and men, time to pregnancy, and risk of miscarriage

Samples from Huanan Seafood Market provide further evidence of COVID-19 animal origins

City of Hope vaccine experts report positive results on Phase 1 trial of personalized vaccine for lymphoplasmacytic lymphoma

Global assessment: How to make climate adaptation a success

The African Engineering and Technology Network signs eighth university partner

Researchers awarded $1.14M to use artificial intelligence to determine best rectal cancer treatment strategy

A new ventilator-on-a-chip model to study lung damage

Enrollment of undocumented students at California universities dropped from 2016 to 2023

Gaining insights into the chemical basis of aversive learning

Revolutionary visible-light-antenna ligand enhances samarium-catalyzed reactions

Stopping plants from passing viruses to their progeny

​​​​​​​NIH awards $2.8M to Rice, Baylor College of Medicine for research on acute respiratory distress syndrome

The University of Limpopo chooses Figshare to support its research excellence strategy

A new forecasting model based on gene activity predicts when Japan’s cherry buds awake from dormancy

New organic thermoelectric device that can harvest energy at room temperature

Activity in brain system that controls eye movements highlights importance of spatial thinking

New research reenvisions Earth’s mantle as a relatively uniform reservoir

Global warming leads to drier and hotter Amazon: reducing uncertainty in future rainforest carbon loss

Low-carbon ammonia offers green alternative for agriculture and hydrogen transport

New mechanism uncovered for the reduction of emu wings

Zeroing in on the genes that snakes use to produce venom

Maynooth University study reveals impact of homework on student achievement in maths and science

Reducing floodplain development doesn’t need to be complex

[Press-News.org] Re-evaluating the time of your life
Tel Aviv University researcher investigates the 'subjective time trajectory' in psychological health